Mural Oncology Newsroom

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 14 21:34

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 14 20:32

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Mural Oncology Plc (MURA) and Copa Holdings (CPA)

TipRanksNov 14 20:03

Mural Oncology Analyst Ratings

BenzingaNov 14 17:50

H.C. Wainwright Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $18

Futu NewsNov 14 01:31

Promising Developments in Mural Oncology Plc's Pipeline Reinforce Buy Rating

TipRanksNov 14 01:00

Mural Oncology Price Target Announced at $18.00/Share by HC Wainwright & Co.

Dow JonesOct 17 19:09

Raymond James Initiates Mural Oncology(MURA.US) With Buy Rating, Announces Target Price $18

Futu NewsOct 4 21:31

Mural Oncology Analyst Ratings

BenzingaOct 4 19:53

Raymond James Initiates Mural Oncology at Strong Buy With $18 Price Target

MT NewswiresOct 4 19:02

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Futu NewsSep 27 10:32

Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13

Futu NewsSep 9 20:34

Buy Rating Affirmed for Mural Oncology Plc on Promising Clinical Trials and Innovative Cancer Therapies

TipRanksSep 9 20:19

Mural Oncology Analyst Ratings

BenzingaJun 29 00:48

Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15

BenzingaJun 29 00:48

Mural Oncology Analyst Ratings

BenzingaApr 4 18:40

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

BenzingaApr 4 18:40